First treatment for sickle cell side-effect in 20 years approved
The first new treatment in 20 years that prevents a common, painful side-effect in patients with sickle cell disorder (SCD) has been issued interim acceptance by the Scottish Medicines Consortium (SMC). The SMC issued interim acceptance for Novartis UK’s Adakveo for use in NHS Scotland as a… Read More